Pancreatic Neuroendocrine Tumours

Full Article

MHC Lam, W Cheuk, TK Au Yong, HC Cheng, RKC Ngan

Hong Kong J Radiol 2017;20:292-302

DOI: 10.12809/hkjr1716443

Neuroendocrine tumours (NETs) are a heterogeneous group of malignancies that can arise in different organs. Although NETs account for only 0.5% of all malignancies, their incidence has significantly increased in recent years. In the Asia Pacific region, the most common site of primary NETs is the pancreas. Many new treatment modalities have been shown to be effective in treating NETs. This study reviews the diagnosis, management, and prognosis of pancreatic NETs.

Authors' affiliations:
MHC Lam¹, W Cheuk², TK Au Yong³, HC Cheng¹, RKC Ngan^1
1Department of Clinical Oncology, Queen Elizabeth Hospital, Jordan, Hong Kong
²Department of Pathology, Queen Elizabeth Hospital, Jordan, Hong Kong
³Department of Nuclear Medicine, Queen Elizabeth Hospital, Jordan, Hong Kong

中文摘要

胰腺神經內分泌腫瘤

林河清、卓華、歐陽定勤、鄭海清、顏繼昌

神經內分泌腫瘤（NETs）是能在不同器官中出現的異質性惡性腫瘤組織。儘管NETs僅佔所有惡性腫瘤的0.5%，但其發病率近年來顯著增加。在亞太地區，原發性NETs最常見的部位為胰腺。許多新的治療方式顯示能有效治療NETs。本文回顧了胰腺NETs的診斷、治療和預後。